Loading institutional data...
Loading institutional data...
Held by 359 of 5,944 reporting institutions (95th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $32.63 today, the market must believe free cash flow compounds 8.8%/yr for a decade (off $442M normalized FCF).
The market's 8.8% is more optimistic than its 8-yr track record.
2-stage DCF · 0.22B shares · net debt $2.5B
mean 19.1% · volatility σ 80% · implied rate exceeded in 2/8 yrs
Central path = implied 8.8%/yr growth; shaded band = ±1σ (80%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $165M buybacks = $165M returned on $453M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 7%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $657M covers the $20M due within a year 32.9× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~5.5% on $3.2B of debt.
Cash of $657M fully covers short-term debt of $20M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.12B 100.0% | $5.28B 100.0% | $5.18B 100.0% | $4.88B 100.0% | $4.42B 100.0% | $3.74B 100.0% | $4.48B 100.0% | $4.70B 100.0% | $4.38B 100.0% | $4.09B 100.0% |
| Cost of Revenue | $3.35B 65.6% | $3.48B 65.9% | $3.57B 68.8% | $3.47B 71.0% | $2.99B 67.6% | $2.46B 65.8% | $2.92B 65.1% | $3.11B 66.1% | $2.78B 63.5% | $2.53B 61.8% |
| Cost of Products | — | — | — | — | — | — | — | — | $2.78B 63.5% | $2.53B 61.8% |
| Research & Development | $71.0M 1.4% | $74.0M 1.4% | $74.0M 1.4% | $66.0M 1.4% | $62.4M 1.4% | $55.2M 1.5% | $70.2M 1.6% | $73.1M 1.6% | $65.3M 1.5% | $57.7M 1.4% |
| Selling, General & Admin | $805.0M 15.7% | $847.0M 16.1% | $840.0M 16.2% | $772.0M 15.8% | $738.7M 16.7% | $695.0M 18.6% | $822.1M 18.3% | $876.4M 18.7% | $934.7M 21.4% | $959.8M 23.5% |
| Operating Income | $735.0M 14.4% | $706.0M 13.4% | $588.0M 11.3% | $423.0M 8.7% | $462.4M 10.5% | $305.5M 8.2% | $488.2M 10.9% | $442.1M 9.4% | $363.7M 8.3% | $405.1M 9.9% |
| Interest Expense | $176.0M 3.4% | $205.0M 3.9% | $213.0M 4.1% | $139.8M 2.9% | $134.2M 3.0% | $149.9M 4.0% | $162.6M 3.6% | $159.6M 3.4% | $147.0M 3.4% | $178.2M 4.4% |
| Other Income (Expense), net | -$13.0M -0.3% | -$5.0M -0.1% | -$20.0M -0.4% | -$26.0M -0.5% | $12.3M 0.3% | -$33.4M -0.9% | $4.4M 0.1% | -$15.0M -0.3% | -$27.1M -0.6% | -$144.2M -3.5% |
| Pretax Income | $546.0M 10.7% | $496.0M 9.4% | $355.0M 6.8% | $257.0M 5.3% | $340.5M 7.7% | $122.2M 3.3% | $330.0M 7.4% | $267.5M 5.7% | $189.6M 4.3% | $82.7M 2.0% |
| Income Tax Expense | $167.0M 3.3% | $105.0M 2.0% | $86.0M 1.7% | $65.0M 1.3% | $76.1M 1.7% | $200K 0.0% | $77.4M 1.7% | $54.2M 1.2% | $141.9M 3.2% | $38.1M 0.9% |
| Net Income | $379.0M 7.4% | $391.0M 7.4% | $269.0M 5.2% | $192.0M 3.9% | $264.0M 6.0% | $121.6M 3.3% | $249.0M 5.6% | $207.1M 4.4% | $36.7M 0.8% | $38.8M 0.9% |
| Per Share | ||||||||||
| EPS (Basic) | $1.75 | $1.78 | $1.21 | $0.86 | $1.14 | $0.52 | $1.06 | $0.87 | $0.15 | $0.16 |
| EPS (Diluted) | $1.74 | $1.78 | $1.21 | $0.86 | $1.14 | $0.52 | $1.06 | $0.85 | $0.15 | $0.16 |
| Weighted Avg Shares (Basic) | 216.0M | 219.3M | 221.0M | 221.7M | 231.0M | 235.2M | 233.9M | 239.0M | 240.4M | 238.1M |
| Weighted Avg Shares (Diluted) | 217.0M | 220.4M | 221.9M | 222.3M | 231.9M | 236.0M | 235.8M | 242.9M | 246.1M | 244.4M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-09-17
Where each multiple sits in its own 12-yr range · 20th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 12-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 66.1 | 65.1 | 65.8 | 67.6 | 71.0 | 68.8 | 65.9 | 65.6 |
| R&D | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 |
| SG&A | 18.7 | 18.3 | 18.6 | 16.7 | 15.8 | 16.2 | 16.1 | 15.7 |
| Operating Income | 9.4 | 10.9 | 8.2 | 10.5 | 8.7 | 11.3 | 13.4 | 14.4 |
| Income Tax | 1.2 | 1.7 | 0.0 | 1.7 | 1.3 | 1.7 | 2.0 | 3.3 |
| Net Income | 4.4 | 5.6 | 3.3 | 6.0 | 3.9 | 5.2 | 7.4 | 7.4 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on AXTA: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 238 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BHP | $439.4B | — | — | — | — | — | — | — | — | — | 713 |
| LIN | $215.3B | 31.4× | 19.3× | 6.3× | 3.0% | — | 20.3% | 18.0% | 10.9% | 2.1× | 2,148 |
| SCCO | $162.1B | 37.4× | 20.9× | 12.1× | 17.4% | 60.1% | 32.4% | 39.4% | 24.4% | 0.9× | 791 |
| CX | $147.8B | — | — | — | — | — | — | — | — | — | 297 |
| TX | $116.5B | — | — | — | — | — | — | — | — | — | 139 |
| FCX | $101.8B | — | 12.3× | 3.9× | 1.8% | 28.2% | 16.0% | 22.0% | 14.7% | 1.1× | 1,775 |
| AEM | $100.7B | — | — | — | — | — | — | — | — | — | 1,066 |
| SHW | $79.5B | 31.3× | — | 3.4× | 2.1% | 48.8% | 10.9% | 55.9% | 17.0% | — | 1,610 |
| ECL | $76.6B | 37.3× | 22.5× | 4.8× | 2.2% | 44.5% | 12.9% | 21.2% | 19.5% | 0.3× | 1,619 |
| B | $73.2B | — | — | — | — | — | — | — | — | — | 979 |
| WPM | $69.1B | — | — | — | — | — | — | — | — | — | 809 |
| APD | $63.7B | — | 90.0× | 5.3× | -0.5% | 31.4% | -3.3% | -2.6% | -2.6% | 0.1× | 1,702 |
| VALE | $61.6B | — | — | — | — | — | — | — | — | — | 537 |
| NUE | $61.2B | 35.3× | — | 1.9× | 5.7% | 11.9% | 5.4% | 8.3% | 8.3% | — | 1,325 |
| CRH | $58.0B | 15.7× | 9.3× | 1.6× | 5.3% | 36.1% | 10.0% | 15.6% | 9.2% | 2.2× | 9 |
| MT | $57.2B | — | — | — | — | — | — | — | — | — | 286 |
| DD | $53.6B | — | — | 7.8× | 1.9% | 34.5% | -11.4% | -5.6% | -5.6% | — | 1,172 |
| AU | $51.7B | — | — | — | — | — | — | — | — | — | 537 |
| FNV | $51.4B | — | — | — | — | — | — | — | — | — | 614 |
| NTR | $37.7B | — | — | — | — | — | — | — | — | — | 718 |
| STLD | $35.6B | 30.7× | 19.2× | 2.0× | 3.6% | 13.2% | 6.5% | 13.2% | 9.0% | 2.1× | 893 |
| KGC | $34.2B | — | — | — | — | — | — | — | — | — | 630 |
| VMC | $31.9B | 30.1× | 15.3× | 4.0× | 7.1% | 27.4% | 13.6% | 12.6% | 8.4% | 1.8× | 981 |
| MLM | $29.8B | 26.3× | 16.9× | 4.8× | 8.6% | 30.7% | 18.5% | 11.3% | 7.4% | 2.6× | 1,022 |
| PPG | $23.6B | 15.2× | — | 1.5× | 0.2% | 41.3% | 9.9% | 19.8% | 10.3% | — | 1,003 |
| AXTA | $7.0B | 18.8× | 11.1× | 1.4× | -3.0% | 34.4% | 7.4% | 16.1% | 6.8% | 3.7× | 359 |
Peers = companies sharing AXTA's sector (Basic Materials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.